Classification of anticancer drugs: an update with FDA- and EMA-approved drugs
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Classification of anticancer drugs: an update with FDA- and EMA-approved drugs ; day:5 ; month:7 ; year:2024 ; pages:1-11
Cancer and metastasis reviews ; (5.7.2024), 1-11
- Urheber
-
Ostios-Garcia, Lorena
Pérez, Daniel Martínez
Castelo, Beatriz
Herradón, Noelia Hernández
Zamora, Pilar
Feliu, Jaime
Espinosa, Enrique
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10555-024-10188-5
- URN
-
urn:nbn:de:101:1-2409232102466.175228949956
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ostios-Garcia, Lorena
- Pérez, Daniel Martínez
- Castelo, Beatriz
- Herradón, Noelia Hernández
- Zamora, Pilar
- Feliu, Jaime
- Espinosa, Enrique
- SpringerLink (Online service)
Ähnliche Objekte (12)
A systematic analysis of FDA-approved anticancer drugs
The First FDA-Approved Antibody-Drug Conjugate
Repurposing FDA-approved drugs for anti-aging therapies
Scaffold Searching of FDA and EMA-Approved Drugs Identifies Lead Candidates for Drug Repurposing in Alzheimer’s Disease
The FDA-approved anti-cancer drugs, streptozotocin and floxuridine, reduce the virulence of Staphylococcus aureus
Evaluierung von FDA-approved Drugs gegen das Humane Cytomegalievirus
FDA‐approved drugs featuring macrocycles or medium‐sized rings
Repurposing von FDA-approved drugs zur Therapie des humanen Cytomegalievirus
Identification of FDA-approved drugs targeting the Farnesoid X Receptor
Study of serious adverse drug reactions using FDA-approved drug labeling and MedDRA
Repurposing FDA approved drugs against the human fungal pathogen, Candida albicans
Repurposing FDA approved drugs as radiosensitizers for treating hypoxic prostate cancer
A systematic analysis of FDA-approved anticancer drugs
The First FDA-Approved Antibody-Drug Conjugate
Repurposing FDA-approved drugs for anti-aging therapies
Scaffold Searching of FDA and EMA-Approved Drugs Identifies Lead Candidates for Drug Repurposing in Alzheimer’s Disease
The FDA-approved anti-cancer drugs, streptozotocin and floxuridine, reduce the virulence of Staphylococcus aureus
Evaluierung von FDA-approved Drugs gegen das Humane Cytomegalievirus
FDA‐approved drugs featuring macrocycles or medium‐sized rings
Repurposing von FDA-approved drugs zur Therapie des humanen Cytomegalievirus
Identification of FDA-approved drugs targeting the Farnesoid X Receptor
Study of serious adverse drug reactions using FDA-approved drug labeling and MedDRA
Repurposing FDA approved drugs against the human fungal pathogen, Candida albicans
Repurposing FDA approved drugs as radiosensitizers for treating hypoxic prostate cancer
A systematic analysis of FDA-approved anticancer drugs
The First FDA-Approved Antibody-Drug Conjugate
Repurposing FDA-approved drugs for anti-aging therapies
Scaffold Searching of FDA and EMA-Approved Drugs Identifies Lead Candidates for Drug Repurposing in Alzheimer’s Disease
The FDA-approved anti-cancer drugs, streptozotocin and floxuridine, reduce the virulence of Staphylococcus aureus
Evaluierung von FDA-approved Drugs gegen das Humane Cytomegalievirus
FDA‐approved drugs featuring macrocycles or medium‐sized rings
Repurposing von FDA-approved drugs zur Therapie des humanen Cytomegalievirus
Identification of FDA-approved drugs targeting the Farnesoid X Receptor
Study of serious adverse drug reactions using FDA-approved drug labeling and MedDRA
Repurposing FDA approved drugs against the human fungal pathogen, Candida albicans